These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 26025872

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reconstitution of CMV pp65 and IE-1-specific IFN-γ CD8(+) and CD4(+) T-cell responses affording protection from CMV DNAemia following allogeneic hematopoietic SCT.
    Tormo N, Solano C, Benet I, Nieto J, de la Cámara R, López J, Garcia-Noblejas A, Muñoz-Cobo B, Costa E, Clari MA, Hernández-Boluda JC, Remigia MJ, Navarro D.
    Bone Marrow Transplant; 2011 Nov; 46(11):1437-43. PubMed ID: 21243030
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. An evaluation of the role of NKG2C+ natural killer cells in protection from cytomegalovirus DNAemia early following allogeneic stem cell transplantation.
    Muñoz-Cobo B, Giménez E, Solano C, de la Cámara R, Nieto J, López J, Amat P, Garcia-Noblejas A, Navarro D.
    J Med Virol; 2014 May; 86(5):806-11. PubMed ID: 24105728
    [Abstract] [Full Text] [Related]

  • 7. Enumeration of NKG2C+ natural killer cells early following allogeneic stem cell transplant recipients does not allow prediction of the occurrence of cytomegalovirus DNAemia.
    Giménez E, Solano C, Amat P, de la Cámara R, Nieto J, López J, Garcia-Noblejas A, Navarro D.
    J Med Virol; 2015 Sep; 87(9):1601-7. PubMed ID: 25802229
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Tetramer-based quantification of cytomegalovirus (CMV)-specific CD8+ T lymphocytes in T-cell-depleted stem cell grafts and after transplantation may identify patients at risk for progressive CMV infection.
    Gratama JW, van Esser JW, Lamers CH, Tournay C, Löwenberg B, Bolhuis RL, Cornelissen JJ.
    Blood; 2001 Sep 01; 98(5):1358-64. PubMed ID: 11520783
    [Abstract] [Full Text] [Related]

  • 10. An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation.
    Tormo N, Solano C, de la Cámara R, Garcia-Noblejas A, Cardeñoso L, Clari MA, Nieto J, López J, Hernández-Boluda JC, Remigia MJ, Benet I, Navarro D.
    Biol Blood Marrow Transplant; 2010 May 01; 16(5):653-61. PubMed ID: 20005968
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.
    Eid AJ, Brown RA, Hogan WJ, Lahr BD, Eckel-Passow JE, Litzow MR, Razonable RR.
    Transpl Infect Dis; 2009 Dec 01; 11(6):519-28. PubMed ID: 19744286
    [Abstract] [Full Text] [Related]

  • 13. Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.
    Fleming T, Dunne J, Crowley B.
    J Med Virol; 2010 Mar 01; 82(3):433-40. PubMed ID: 20087937
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Levels of CMV specific CD4 T cells are dynamic and correlate with CMV viremia after allogeneic stem cell transplantation.
    Widmann T, Sester U, Gärtner BC, Schubert J, Pfreundschuh M, Köhler H, Sester M.
    PLoS One; 2008 Mar 01; 3(11):e3634. PubMed ID: 18982061
    [Abstract] [Full Text] [Related]

  • 17. Dynamics of cytomegalovirus-specific T-cell recovery in allogeneic hematopoietic cell transplant recipients using a commercially available flow cytometry assay: A pilot study.
    Jacobs SE, Ibrahim U, Vega AB, Lagdameo J, Callahan J, Govindarajulu U, Gitman M, Levine JE, Rana M, Keyzner A.
    Transpl Infect Dis; 2024 Jun 01; 26(3):e14290. PubMed ID: 38708941
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients.
    Ciáurriz M, Beloki L, Zabalza A, Bandrés E, Mansilla C, Pérez-Valderrama E, Lachén M, Rodríguez-Calvillo M, Ramírez N, Olavarría E.
    Transpl Infect Dis; 2017 Dec 01; 19(6):. PubMed ID: 28921749
    [Abstract] [Full Text] [Related]

  • 20. Monitoring of oral cytomegalovirus DNA shedding for the prediction of viral DNAemia in allogeneic hematopoietic stem cell transplant recipients.
    Pascual T, Solano C, Torres I, Talaya A, Giménez E, Vinuesa V, Piñana JL, Hernández-Boluda JC, Pérez A, Navarro D.
    J Med Virol; 2018 Aug 01; 90(8):1375-1382. PubMed ID: 29663435
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.